Evidence of pre-procedural statin therapy: A meta-analysis of randomized trials

Journal of the American College of Cardiology

Volumn 56, Issue 14, 2010, Pages 1099-1109

  Winchester, David E ^a   Wen, Xuerong ^b   Xie, Lola ^a   Bavry, Anthony A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

meta analysis; outcomes; periprocedural myocardial infarction; post operative myocardial infarction; statin

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PROCEDURES; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEATH; DRUG SAFETY; EVIDENCE BASED PRACTICE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INVASIVE PROCEDURE; META ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK REDUCTION; SYSTEMATIC REVIEW; ATRIAL FIBRILLATION; EVIDENCE BASED MEDICINE; FEMALE; MALE; MORTALITY; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SECONDARY PREVENTION; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY; SECONDARY PREVENTION;

EID: 77957189546     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.04.023     Document Type: Article

References (57)

1. D.L. Bhatt, and E.J. Topol Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes Circulation 112 2005 906 915
2. F. Onorati, M. De Feo, and P. Mastroroberto Determinants and prognosis of myocardial damage after coronary artery bypass grafting Ann Thorac Surg 79 2005 837 845 (Pubitemid 40288732)
3. G. Landesberg, V. Shatz, and I. Akopnik Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery J Am Coll Cardiol 42 2003 1547 1554
4. E.J. Topol, J.J. Ferguson, H.F. Weisman EPIC investigator group Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention Evaluation of platelet IIb/IIIa inhibition for prevention of ischemic complication JAMA 278 1997 479 484
5. L.A. Fleisher, J.A. Beckman, and K.A. Brown ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary J Am Coll Cardiol 50 2007 1707 1732
6. S. Bangalore, J. Wetterslev, S. Pranesh, S. Sawhney, C. Gluud, and F.H. Messerli Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis Lancet 372 2008 1962 1976
7. D. Poldermans, O. Schouten, and R. Vidakovic A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V pilot study J Am Coll Cardiol 49 2007 1763 1769
8. E.O. McFalls, H.B. Ward, and T.E. Moritz Coronary-artery revascularization before elective major vascular surgery N Engl J Med 351 2004 2795 2804
9. J.A. de Lemos, M.A. Blazing, and S.D. Wiviott Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316
10. A.A. Bavry, G.R. Mood, D.J. Kumbhani, P.P. Borek, A.T. Askari, and D.L. Bhatt Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials Am J Cardiovasc Drugs 7 2007 135 141
11. E. Hulten, J.L. Jackson, K. Douglas, S. George, and T.C. Villines The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials Arch Intern Med 166 2006 1814 1821
12. V. Pasceri, G. Patti, and A. Nusca Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study Circulation 110 2004 674 678
13. O. Schouten, E. Boersma, and S.E. Hoeks Fluvastatin and perioperative events in patients undergoing vascular surgery N Engl J Med 361 2009 980 989
14. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
15. S.G. Thompson, and J.P. Higgins How should meta-regression analyses be undertaken and interpreted? Stat Med 21 2002 1559 1573
16. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46
17. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
18. K.H. Yun, M.H. Jeong, and S.K. Oh The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome Int J Cardiol 137 2009 246 251
19. J. Veselka, D. Zemanek, and P. Hajek Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study Am J Cardiol 104 2009 630 633
20. C. Briguori, G. Visconti, and A. Focaccio Novel approaches for preventing or limiting events (NAPLES) II trial impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction J Am Coll Cardiol 54 2009 2157 2163
21. X.W. Jia, X.H. Fu, and J. Zhang Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome Chin Med J (Engl) 122 2009 659 664
22. G. Di Sciascio, G. Patti, V. Pasceri, A. Gaspardone, G. Colonna, and A. Montinaro Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) randomized trial J Am Coll Cardiol 54 2009 558 565
23. G. Patti, V. Pasceri, and G. Colonna Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial J Am Coll Cardiol 49 2007 1272 1278
24. M. Kinoshita, S. Matsumura, K. Sueyoshi, S. Ogawa, and K. Fukuda Randomized trial of statin administration for myocardial injury: is intensive lipid-lowering more beneficial than moderate lipid-lowering before percutaneous coronary intervention? Circ J 71 2007 1225 1228
25. H. Bozbas, A. Yildirir, and S. Mermer Does pravastatin therapy affect cardiac enzyme levels after percutaneous coronary intervention? Adv Ther 24 2007 493 504
26. C. Briguori, A. Colombo, and F. Airoldi Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction Eur Heart J 25 2004 1822 1828
27. Q. Ji, Y. Mei, and X. Wang Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting Circ J 73 2009 2244 2249
28. O. Berkan, N. Katrancioglu, E. Ozker, G. Ozerdem, Z. Bakici, and M.B. Yilmaz Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery Thorac Cardiovasc Surg 57 2009 91 95
29. V.A. Mannacio, D. Iorio, V. De Amicis, F. Di Lello, and F. Musumeci Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial J Thorac Cardiovasc Surg 136 2008 1541 1548
30. Y.B. Song, Y.K. On, and J.H. Kim The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery Am Heart J 156 2008 373 e916
31. E. Tamayo, O. Alonso, F.J. Alvarez, J. Castrodeza, S. Florez, and S. di Stefano Effects of simvastatin on acute-phase protein levels after cardiac surgery Med Clin (Barc) 130 2008 773 775
32. G. Patti, M. Chello, and D. Candura Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 study Circulation 114 2006 1455 1461
33. M. Chello, G. Patti, and D. Candura Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery Crit Care Med 34 2006 660 667
34. J.T. Christenson Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG Eur J Cardiothorac Surg 15 1999 394 399
35. M. Dunkelgrun, E. Boersma, and O. Schouten Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV) Ann Surg 249 2009 921 926
36. A.E. Durazzo, F.S. Machado, and D.T. Ikeoka Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial J Vasc Surg 39 2004 967 975 discussion 9756
37. C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
38. M.C. Kramer, S.Z. Rittersma, and R.J. de Winter Relationship of thrombus healing to underlying plaque morphology in sudden coronary death J Am Coll Cardiol 55 2010 122 132
39. S. Okazaki, T. Yokoyama, and K. Miyauchi Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study Circulation 110 2004 1061 1068
40. M. Schartl, W. Bocksch, and D.H. Koschyk Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease Circulation 104 2001 387 392
41. C.B. Treasure, J.L. Klein, and W.S. Weintraub Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 1995 481 487
42. S. John, M.P. Schneider, C. Delles, J. Jacobi, and R.E. Schmieder Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients Am Heart J 149 2005 473
43. C. Vlachopoulos, K. Aznaouridis, and A. Dagre Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects Eur Heart J 28 2007 2102 2109
44. M. Pirro, G. Schillaci, and P.F. Romagno Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function J Cardiovasc Pharmacol Ther 14 2009 14 21
45. J.H. Bae, E. Bassenge, K.Y. Kim, Y.C. Synn, K.R. Park, and M. Schwemmer Effects of low-dose atorvastatin on vascular responses in patients undergoing percutaneous coronary intervention with stenting J Cardiovasc Pharmacol Ther 9 2004 185 192
46. M.H. Shishehbor, M.L. Brennan, and R.J. Aviles Statins promote potent systemic antioxidant effects through specific inflammatory pathways Circulation 108 2003 426 431
47. P.M. Ridker, E. Danielson, and F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
48. P. Libby, P.M. Ridker, and G.K. Hansson Leducq Transatlantic Network on Atherothrombosis Inflammation in atherosclerosis: from pathophysiology to practice J Am Coll Cardiol 54 2009 2129 2138
49. E.J. Mills, B. Rachlis, P. Wu, P.J. Devereaux, P. Arora, and D. Perri Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients J Am Coll Cardiol 52 2008 1769 1781
50. C. Newman, J. Tsai, M. Szarek, D. Luo, and E. Gibson Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients Am J Cardiol 97 2006 61 67
51. O. Schouten, M.D. Kertai, and J.J. Bax Safety of perioperative statin use in high-risk patients undergoing major vascular surgery Am J Cardiol 95 2005 658 660
52. D. Trenk, W. Hochholzer, and D. Frundi Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement Thromb Haemost 99 2008 174 181
53. A. Undas, K.E. Brummel, J. Musial, K.G. Mann, and A. Szczeklik Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation Circulation 103 2001 2248 2253
54. J.D. Douketis, M. Melo, C.M. Bell, and M.M. Mamdani Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin? Am J Med 120 2007 369 e914
55. K.A. Eagle, R.A. Guyton, and R. Davidoff ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) J Am Coll Cardiol 44 2004 1146 1154
56. S.B. King 3rd, S.C. Smith Jr., and J.W. Hirshfeld Jr. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 172 209
57. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 50 2007 e1 e157